Skip to main content
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.09
+1.16 (1.90%)
At close: Apr 28, 2026, 4:00 PM EDT
64.01
+1.92 (3.09%)
After-hours: Apr 28, 2026, 6:30 PM EDT

Tarsus Pharmaceuticals Revenue

In the year 2025, Tarsus Pharmaceuticals had annual revenue of $451.36M with 146.71% growth. Tarsus Pharmaceuticals had revenue of $151.67M in the quarter ending December 31, 2025, with 128.39% growth.

Revenue (ttm)
$451.36M
Revenue Growth
+146.71%
P/S Ratio
5.85
Revenue / Employee
$1,219,892
Employees
370
Market Cap
2.64B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025451.36M268.41M146.71%
Dec 31, 2024182.95M165.51M948.62%
Dec 31, 202317.45M-8.37M-32.42%
Dec 31, 202225.82M-31.21M-54.73%
Dec 31, 202157.03M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ADMA Biologics 510.17M
Zai Lab 460.16M
IDEAYA Biosciences 218.71M
Soleno Therapeutics 190.41M
Relay Therapeutics 15.36M
Immunome 6.94M
Celldex Therapeutics 1.55M
Revenue Rankings

TARS News

More News